Effect of insulin analogues on insulin/IGF1 hybrid receptors: increased activation by glargine but not by its metabolites M1 and M2
about
The links between insulin resistance, diabetes, and cancerImpact of glucose-lowering agents on the risk of cancer in type 2 diabetic patients. The Barcelona case-control studyDevelopment of a human breast-cancer derived cell line stably expressing a bioluminescence resonance energy transfer (BRET)-based phosphatidyl inositol-3 phosphate (PIP3) biosensorClinical utility of insulin and insulin analogs.A framework for the in vitro evaluation of cancer-relevant molecular characteristics and mitogenic potency of insulin analogues.CRISPR Cas9-guided chromatin immunoprecipitation identifies miR483 as an epigenetic modulator of IGF2 imprinting in tumors.Glargine safety, diabetes and cancer.Insulin receptor (IR) and insulin-like growth factor receptor 1 (IGF-1R) signaling systems: novel treatment strategies for cancer.Identification of the IGF1/PI3K/NF κB/ERK gene signalling networks associated with chemotherapy resistance and treatment response in high-grade serous epithelial ovarian cancerTreatment with insulin (analogues) and breast cancer risk in diabetics; a systematic review and meta-analysis of in vitro, animal and human evidence.Glargine and cancer: can we now suggest closure?BRET Biosensor Analysis of Receptor Tyrosine Kinase Functionality.Differences in metabolic and mitogenic signallingof insulin glargine and AspB10 human insulin in rats [corrected].Concentrations of insulin glargine and its metabolites during long-term insulin therapy in type 2 diabetic patients and comparison of effects of insulin glargine, its metabolites, IGF-I, and human insulin on insulin and igf-I receptor signaling.O-GlcNAcylation-inducing treatments inhibit estrogen receptor α expression and confer resistance to 4-OH-tamoxifen in human breast cancer-derived MCF-7 cells.O-GlcNAcylation: A New Cancer Hallmark?Treatment with insulin analogs, especially Glargine and Lispro, associates with better renal function and higher hemoglobin levels in Type 1 diabetic patients with impaired kidney function.Cancer incidence among those initiating insulin therapy with glargine versus human NPH insulin.Diabetes and cancer relationships.Insulin and GH-IGF-I axis: endocrine pacer or endocrine disruptor?The use of insulin detemir during pregnancy: a safety evaluation.Tau deletion promotes brain insulin resistancePrevention of tumour cell apoptosis associated with sustained protein kinase B phosphorylation is more sensitive to regulation by insulin signalling than stimulation of proliferation and extracellular signal-regulated kinase.Effect of insulin analogues on phosphatidyl inositol-3 kinase/Akt signalling in INS-1 rat pancreatic derived β-cells.Obesity and Cancer Mechanisms: Cancer Metabolism.Hijacking of the O-GlcNAcZYME complex by the HTLV-1 Tax oncoprotein facilitates viral transcription.Direct comparison of radioimmunoassay and LC-MS/MS for PK assessment of insulin glargine in clinical development.Analysis of fast protein phosphorylation kinetics in single cells on a microfluidic chip.Identification of insulin-sensitizing molecules acting by disrupting the interaction between the Insulin Receptor and Grb14.Insulin-Like Growth Factor 1 in the Cardiovascular System.Insulin Receptor Isoforms in Physiology and Disease: An Updated View.Targeting the IGF1R Pathway in Breast Cancer Using Antisense lncRNA-Mediated Promoter cis Competition.
P2860
Q26852910-C6360E33-231D-488D-8CFC-E0B5D5D39ED8Q28535372-3519F302-0C1A-4B0C-B152-27E9783EFA07Q28541161-48F909B8-C782-4042-B711-13D0B06C73FEQ30429358-FBC182C0-DBC1-45D8-B1AE-E4BBF0AD51E2Q30662831-F9B76301-CF26-484B-9BEE-CB0CE3CD50C6Q33798311-28A2BDE9-D4C1-4976-827F-E643AB13DC59Q34326924-C12E0A9F-6A57-42A9-8F2D-0C77D2292009Q34391968-1188AE1C-5CB8-4055-B3B1-903B3A28B502Q35044404-314D566C-6321-4F93-9276-B06801BF6450Q35937961-121BD140-5850-40C3-B21B-985E29C38C22Q36426885-347A85C1-B70D-456D-9090-09A6AD96DB18Q36750306-6FBD6EA7-AE90-46EC-83A2-5DC158BE6AC5Q36976992-EAF2EC7C-4817-4DA7-B534-F66B4194A142Q37014889-D4E0F6C9-D584-4831-BFE6-C8AA3D330A63Q37062403-3A13CF6D-C006-4FC3-973F-AAD9205B545BQ37086952-7D7D618E-5A75-4F27-9512-5EFE29039E8AQ37151682-F0AFDF7C-F4C6-4CBB-BC31-10B51C3B78EEQ37278227-57132F1F-6D63-4E20-8123-C260D77ECF2AQ38097984-D8442626-4195-4852-8805-C48BB5316DB1Q38239532-DD4A3E41-4AFB-41B7-B270-6226FA43CC61Q38366782-21DA22B5-5FFF-413E-A394-9DA19B247991Q38708062-3E92FB68-8EDB-42B9-A89E-D4E4863BA899Q38711630-E7418B1A-126E-4913-B2B4-15313DF8693DQ38808885-23289565-1DF8-45B8-B5E1-CD3AA0A2899CQ39024765-2CC8AFEF-BD15-417D-92B3-1C221B85B3EAQ40109280-A81C3EFA-E26C-432F-B3D1-F77E2B955521Q41656524-078536DD-4D88-494D-B537-A6487F9C146DQ42833323-F668058B-12C8-4E5C-BE9E-3902CA5A7486Q47161167-336CEE0B-CD75-437F-9DE9-6D2903F350A5Q47222500-9B55AF6C-BCBD-4B1E-BF00-44316A08FFCCQ47668280-2C1DFC0D-7225-43F9-B6FF-64B336CF2159Q55438295-0D3BB47D-4AA4-4080-A341-3C14A3D9D6D5
P2860
Effect of insulin analogues on insulin/IGF1 hybrid receptors: increased activation by glargine but not by its metabolites M1 and M2
description
2012 թուականին հրատարակուած գիտական յօդուած
@hyw
2012 թվականին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 2012
@ast
im Januar 2012 veröffentlichter wissenschaftlicher Artikel
@de
scientific article (publication date: 2012)
@en
vedecký článok (publikovaný 2012)
@sk
vědecký článek publikovaný v roce 2012
@cs
wetenschappelijk artikel (gepubliceerd in 2012)
@nl
наукова стаття, опублікована у 2012
@uk
مقالة علمية (نشرت عام 2012)
@ar
name
Effect of insulin analogues on ...... t by its metabolites M1 and M2
@ast
Effect of insulin analogues on ...... t by its metabolites M1 and M2
@en
Effect of insulin analogues on ...... t by its metabolites M1 and M2
@nl
type
label
Effect of insulin analogues on ...... t by its metabolites M1 and M2
@ast
Effect of insulin analogues on ...... t by its metabolites M1 and M2
@en
Effect of insulin analogues on ...... t by its metabolites M1 and M2
@nl
prefLabel
Effect of insulin analogues on ...... t by its metabolites M1 and M2
@ast
Effect of insulin analogues on ...... t by its metabolites M1 and M2
@en
Effect of insulin analogues on ...... t by its metabolites M1 and M2
@nl
P2093
P2860
P1433
P1476
Effect of insulin analogues on ...... t by its metabolites M1 and M2
@en
P2093
Cornelia Hampe
Cécile Pierre-Eugene
Georg Tschank
Marion Neuillé
Norbert Tennagels
Patrick Pagesy
Tuyet Thu Nguyen
P2860
P304
P356
10.1371/JOURNAL.PONE.0041992
P407
P50
P577
2012-01-01T00:00:00Z